Issuer: Immunic, Inc. / Key word(s): Study results/Strategic Company Decision Immunic Reports Positive Data from Maintenance Phase of Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Moderate-to-Severe Ulcerative Colitis 05.04.2023 / 12:30 CET/CEST The issuer is solely responsible for the cont.
Issuer: Skyborn Renewables GmbH / Key word(s): Personnel/Strategic Company Decision Thomas Karst appointed as CEO of Skyborn Renewables 28.03.2023 / 10:45 CET/CEST The issuer is
Issuer: Skyborn Renewables GmbH / Key word(s): Personnel/Strategic Company Decision Thomas Karst appointed as CEO of Skyborn Renewables 28.03.2023 / 10:45 CET/CEST The issuer is solely responsible for the content of this announcement. Hamburg, Germany, March 28, 2023 Thomas Karst, Skyborn Renewa.
Fresenius Medical Care AG & Co. KGaA / Key word(s): Strategic Company DecisionFresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation21-Feb-2023 / 19:05 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/.